title: Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
abstract: Guillain-Barré syndrome (GBS) is typically classified into two major subtypes: acute inflammatory demyelinating neuropathy and acute motor axonal neuropathy. Its most recognizable variant is Fisher syndrome. The last two decades have seen considerable advances in our understanding of GBS. Of note, various autoantibodies against ganglioside antigens have been identified and found to have significant associations with the axonal forms of GBS and Fisher syndrome. In this article, we discuss the different clinical presentations in GBS and the role of antiganglioside antibodies in their underlying pathogenesis. We also discuss the impact that antiganglioside antibodies have had in the development of experimental models and treatment modalities in GBS.
authors.affiliation: Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Malaysia.
authors.forename: Nortina
authors.initials: N
authors.lastname: Shahrizaila
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Yuki
mesh_terms: D001323:Autoantibodies / Q000502:physiology*; D005732:Gangliosides / Q000276:immunology*; D020275:Guillain-Barre Syndrome / Q000276:immunology* / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D007074:Immunoglobulin G / Q000502:physiology; D019846:Miller Fisher Syndrome / Q000276:immunology* / Q000503:physiopathology* / Q000628:therapy
chemical_list: D001323:Autoantibodies; D005732:Gangliosides; D007074:Immunoglobulin G